Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

5.75
Delayed Data
As of 3:17pm ET
 -0.13 / -2.21%
Today’s Change
5.45
Today|||52-Week Range
19.03
+2.68%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close5.88
Today’s open5.91
Day’s range5.74 - 5.96
Volume45,996
Average volume (3 months)256,802
Market cap$147.8M
Dividend yield--
Data as of 3:17pm ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)-25.40%
Earnings growth (this year)+15.76%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+68.18%
P/E ratio--
Price/Sales34.95
Price/Book1.10

Competitors

 Today’s
change
Today’s
% change
NVIVInVivo Therapeutics ...-0.08-1.69%
VBLTVascular Biogenics L...-0.03-0.48%
EVGNEvogene Ltd-0.03-0.57%
VBIVVBI Vaccines Inc+0.01+0.30%
Data as of 3:17pm ET, 01/18/2017

Financials

Next reporting dateApril 10, 2017
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$10.5M
Annual profit (last year)-$79.3M
Net profit margin-758.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts


Search for Jobs